Resultados de la búsqueda 191-200 of 9470 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  4. Oncología (médica) - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester ...

  9. Oncología (médica) - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...